Conformal Medical begins IDE study of CLAAS System in US
The CONFORM study is said to support the US FDA approval of the company’s CLAAS implant for left…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 Jun 22
The CONFORM study is said to support the US FDA approval of the company’s CLAAS implant for left…
20 Jun 22
Renal Denervation with TIVUS is a minimally invasive procedure that uses high-frequency non-focused Ultra-Sound energy to ablate nerves…
13 Jun 22
Existing investor syndicate supports atrial shunting as effective therapy for heart failure patients
08 Jun 22
Okami’s LOBO system was specifically designed for rapid and complete occlusion of various peripheral arterial targets, and now…
25 May 22
The FDA approval will expand inHEART’s commercial footprint in the US and improves the efficacy of cardiac ablation…
24 May 22
The first clinical data of an implantable heart sensor with remote measurement capacity was presented at the prestigious…
18 May 22
As part of the firm’s SPYRAL HTN Global Clinical Programme, the three-year data from SPYRAL HTN-ON MED and…
18 May 22
Funds will support clinical development and regulatory approval of fully absorbable percutaneous closure devices for large-bore vessels
16 May 22
Medtronic said Onyx Frontier DES has undergone meaningful design changes, including enhanced catheter flexibility, advanced dual-layer balloon technology…
16 May 22
The AcQForce Flutter trial was designed to assess the safety and efficacy of the company’s AcQBlate FORCE sensor…